Author

Eric A. Welsh

Moffitt Cancer CenterORCID 0000-0002-9302-3855Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

Bin FangiD· 2 shared Eric B. HauraiD· 2 shared John M. KoomeniD· 2 shared Lily L. Remsing RixiD· 2 shared Uwe RixiD· 2 shared Alexander Drilon· 1 shared Andriy MarusykiD· 1 shared Bina DesaiiD· 1 shared

Activity by Year

2017-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Bin FangORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer-associated fibroblasts confer ALK inhibitor resistance in EML4-ALK-driven lung cancer via concurrent integrin and MET signaling

Qianqian Hu, Lily L. Remsing Rix, Bina Desai, Daria Miroshnychenko, Xueli Li, Eric A. Welsh, Bin Fang, Gabriela M. Wright, Neelkamal Chaudhary, Jodi L. Kroeger, Robert Charles Doebele, John M. Koomen, Eric B. Haura, Andriy Marusyk, Uwe Rix

This study identifies that CAFs confer ALK inhibitor resistance in EML4-ALK-driven lung cancer through both MET and integrin signaling pathways, and shows that targeting both pathways improves treatment efficacy.

Science Signaling · Dec 23, 2025Peer-reviewedCancer Biology

Dual targeting of RET and SRC synergizes in RET fusion-positive cancer cells

Juhyeon Son, Lily L. Remsing Rix, Bin Fang, Eric A. Welsh, Nicole Virginia Bremer, Valentina Foglizzo, Paola Roa, Nickole Sigcha‐Coello, Yi Liao, Eric B. Haura, Alexander Drilon, John M. Koomen, Emiliano Cocco, Uwe Rix

This study shows that combining RET and SRC inhibitors enhances anti-cancer effects in RET fusion-positive cancers by suppressing PAK signaling and restoring sensitivity in resistant cells.

Molecular Oncology · Nov 5, 2025Peer-reviewedCancer Biology

Escape Excel: a tool for preventing gene symbol and accession conversion errors

Eric A. Welsh, Paul A. Stewart, Brent M. Kuenzi, James A. Eschrich

Escape Excel prevents gene symbol and accession conversion errors in Excel by generating escaped text files, available as a Galaxy tool and standalone script.

PLoS ONE · Sep 27, 2017Peer-reviewedBioinformatics